Enlivex Ltd (ENLV)

• Market cap: $197M
• 1 day: -0.46%
• 5 days: -7.27%
• 1 month: -15.2%
• 3 months: -21.54%
• 6 months: -22.29%
• Year to date: 8.09%
• 1 year: -22.29%
• 5 years: -92.88%
• 10 years: -99.09%
• Sector: Healthcare
• Industry: Biotechnology

About: Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Employees: 34